Bank Of America Corp X Biotech Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in X Biotech Inc. stock. As of the latest transaction made, Bank Of America Corp holds 14,001 shares of XBIT stock, worth $52,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,001

Previous 10,363 35.11%

Holding current value

$52,223

Previous $53,000 103.77%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.55 - $7.95 $20,190 - $28,922	3,638 Added 35.11%	14,001 $108,000
Q2 2024 Aug 14, 2024	BUY	$4.54 - $9.89 $7,595 - $16,545	1,673 Added 19.25%	10,363 $53,000
Q1 2024 May 15, 2024	SELL	$4.03 - $8.13 $18,812 - $37,950	-4,668 Reduced 34.95%	8,690 $70,000
Q4 2023 Feb 14, 2024	SELL	$3.56 - $4.65 $1,413 - $1,846	-397 Reduced 2.89%	13,358 $53,000
Q2 2023 Aug 14, 2023	SELL	$3.06 - $6.38 $1,086 - $2,264	-355 Reduced 2.52%	13,755 $81,000
Q1 2023 May 12, 2023	SELL	$3.22 - $4.72 $14,889 - $21,825	-4,624 Reduced 24.68%	14,110 $48,000
Q4 2022 Feb 10, 2023	BUY	$3.03 - $3.79 $34,514 - $43,171	11,391 Added 155.13%	18,734 $65,000
Q3 2022 Nov 14, 2022	SELL	$3.58 - $5.88 $36,394 - $59,776	-10,166 Reduced 58.06%	7,343 $27,000
Q2 2022 Aug 12, 2022	SELL	$5.13 - $9.2 $9,090 - $16,302	-1,772 Reduced 9.19%	17,509 $98,000
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $293,664 - $398,011	-33,989 Reduced 63.81%	19,281 $167,000
Q4 2021 Feb 08, 2022	BUY	$10.95 - $16.07 $200,023 - $293,550	18,267 Added 52.19%	53,270 $593,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $361,654 - $509,388	27,927 Added 394.67%	35,003 $453,000
Q2 2021 Sep 13, 2021	BUY	$15.83 - $17.84 $112,013 - $126,235	7,076 New	7,076 $117,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.87M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $114M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp X Biotech Inc. Transaction History